Pharma lobbyists to EU: Cut deals with Trump
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharma
since
auto-detected in 24 stories
3 days ago
4 days ago
Pharma lobbyists to EU: Cut deals with Trump
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
10 days ago
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
found
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations
23 days ago
Pharma sounds alarm over EU plans to procure novel medicines ⊖
Both the branded and generic drug sectors argue joint procurement can't solve all shortages problems.
37 days ago
Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
68 days ago
Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live
found
a story from The Guardian ⚠️ › International
Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.
GSK’s Emma Walmsley to be replaced as chief executive
I…
71 days ago
Pharma lobby blasts Oct. 1 Trump tariff threat
The European Commission says EU industry should be protected from the latest tariff threat through the EU-U.S. trade deal.
81 days ago
Pharma firms pile pressure on the UK as Trump's drug pricing order looms
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
3 months ago
Rocket Pharma's shares soar after US FDA lets gene therapy trial resume
The drugmaker's shares were up 19% in midday trading after soaring more than 30% earlier Wednesday morning.
Eli Lilly's 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump's pricing pressures
Pharma giants are navigating President Trump's demands to bring U.S. drug prices in line with other developed nations.